Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 6/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAP2 | P11137 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2710628 | 0.94 | ACHE (0.37) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2713008 | 0.89 | MAOB (0.39) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2709935 | 0.89 | HPRT1 (0.37) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2713398 | 0.88 | KDM4E (0.32) | ACHECYP1A2CYP3A4CYP2C19KDM4E | |
| SCHEMBL2711448 | 0.86 | CYP1A2 (0.50) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2711234 | 0.85 | ACHE (0.41) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2725664 | 0.85 | CYP1A2 (0.42) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2726679 | 0.85 | CYP1A2 (0.39) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2710236 | 0.85 | ACHE (0.44) | ACHECYP1A2CYP3A4CYP2C19CYP2C9 | |
| SCHEMBL2727495 | 0.85 | NPSR1 (0.39) | CYP1A2CYP3A4CYP2C19KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| CN-102482573-A | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES INC | 2012-05-30 | — | — | CN | disclosed |
| EP-2445987-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | Cyalume Technologies, Inc (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| WO-2010151654-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECHNOLOGIES, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | ACHE 187/4885CYP1A2 22/4885CYP3A4 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.